Published in J Cell Mol Med on January 15, 2010
Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci U S A (2012) 1.80
The hypoxia factor Hif-1α controls neural crest chemotaxis and epithelial to mesenchymal transition. J Cell Biol (2013) 0.99
Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions. Breast Cancer (Auckl) (2014) 0.98
Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells. Nat Commun (2016) 0.90
Tumor-targeting of EGFR inhibitors by hypoxia-mediated activation. Angew Chem Int Ed Engl (2014) 0.76
RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program. Cell Death Discov (2017) 0.75
Targeting HIF-1 for cancer therapy. Nat Rev Cancer (2003) 28.01
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A (1995) 24.77
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer (2002) 20.51
Cell signaling by receptor tyrosine kinases. Cell (2000) 18.16
Oncogenic kinase signalling. Nature (2001) 16.30
Regulated portals of entry into the cell. Nature (2003) 15.33
Mechanisms of intracellular protein transport. Nature (1994) 13.54
Liver regeneration. Science (1997) 12.80
Caveolin, a protein component of caveolae membrane coats. Cell (1992) 12.50
Endocytosis. Annu Rev Biochem (1977) 11.42
Endocytic recycling. Nat Rev Mol Cell Biol (2004) 10.87
Endocytosis and the recycling of plasma membrane. J Cell Biol (1983) 10.24
Mechanisms of phagocytosis in macrophages. Annu Rev Immunol (1999) 9.66
Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol (2000) 9.16
Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol (2001) 8.93
Endocytosis and molecular sorting. Annu Rev Cell Dev Biol (1996) 8.83
Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med (2003) 8.54
Purification and characterization of hypoxia-inducible factor 1. J Biol Chem (1995) 8.53
The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol (1955) 7.88
The multiple faces of caveolae. Nat Rev Mol Cell Biol (2007) 6.85
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A (1993) 6.77
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell (2003) 6.59
Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol (2007) 6.48
Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem (1987) 5.57
The EGF receptor family as targets for cancer therapy. Oncogene (2000) 5.44
Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem (1996) 5.15
Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J (2000) 4.85
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med (2004) 4.69
Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature (1997) 4.36
GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell (2002) 4.28
Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer (2008) 4.25
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell (2007) 4.10
Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J (1993) 4.09
Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev Cell (2007) 3.84
Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J (2002) 3.81
Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol (1986) 3.78
Rab GTPases in vesicular transport. Curr Opin Cell Biol (1993) 3.59
The ras protein family: evolutionary tree and role of conserved amino acids. Biochemistry (1991) 3.38
Membrane microdomains and caveolae. Curr Opin Cell Biol (1999) 3.34
Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol (2002) 3.34
Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell (2001) 3.25
Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol (2005) 3.20
V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res (1997) 3.17
Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol (2001) 3.14
VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol Biol Cell (1995) 3.05
Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med (2004) 3.04
Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. Mol Biol Cell (2004) 2.99
Rabenosyn-5, a novel Rab5 effector, is complexed with hVPS45 and recruited to endosomes through a FYVE finger domain. J Cell Biol (2000) 2.97
Regulation of receptor-mediated endocytosis by Rho and Rac. Nature (1996) 2.84
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol (2001) 2.71
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res (2001) 2.66
Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol Biol Cell (2003) 2.58
Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res (2001) 2.38
Distinct Rab-binding domains mediate the interaction of Rabaptin-5 with GTP-bound Rab4 and Rab5. EMBO J (1998) 2.20
Renal cell carcinoma. JAMA (2004) 2.19
Endocytosis: clathrin-mediated membrane budding. Curr Opin Cell Biol (2007) 2.17
Involvement of the endosomal autoantigen EEA1 in homotypic fusion of early endosomes. Curr Biol (1998) 2.15
Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest (2003) 2.14
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc Natl Acad Sci U S A (2007) 2.10
Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J Biol Chem (1990) 2.02
Regulation of endocytosis via the oxygen-sensing pathway. Nat Med (2009) 2.00
Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist (2004) 1.88
Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem (2006) 1.83
Rap1-induced p38 mitogen-activated protein kinase activation facilitates AMPA receptor trafficking via the GDI.Rab5 complex. Potential role in (S)-3,5-dihydroxyphenylglycene-induced long term depression. J Biol Chem (2004) 1.79
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol (2001) 1.71
An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells. EMBO Rep (2002) 1.71
Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest (2001) 1.71
Phosphorylation of EEA1 by p38 MAP kinase regulates mu opioid receptor endocytosis. EMBO J (2005) 1.70
The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol (1999) 1.62
Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer Res (2005) 1.61
p38 MAPK in development and cancer. Cell Cycle (2006) 1.61
Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J Biol Chem (2003) 1.60
N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J Virol (2007) 1.59
GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer (2003) 1.56
Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer. Cancer Res (2005) 1.48
Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res (2001) 1.45
Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers. Clin Prostate Cancer (2003) 1.44
AP-2-containing clathrin coats assemble on mature lysosomes. J Cell Biol (1996) 1.43
Identification of alternative spliced variants of human hypoxia-inducible factor-1alpha. J Biol Chem (2000) 1.40
Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer (2004) 1.37
The role of hypoxia-inducible factors in cancer. Cell Mol Life Sci (2007) 1.33
Cancer: Out of air is not out of action. Nature (2003) 1.30
Clathrin adaptors really adapt. Cell (2002) 1.30
Interaction domains: from simple binding events to complex cellular behavior. FEBS Lett (2002) 1.29
Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clin Cancer Res (2004) 1.27
Hypoxia alters biophysical properties of endothelial cells via p38 MAPK- and Rho kinase-dependent pathways. Am J Physiol Cell Physiol (2005) 1.18
Oxygen-dependent and -independent regulation of HIF-1alpha. J Korean Med Sci (2002) 1.15
Endocytic function of von Hippel-Lindau tumor suppressor protein regulates surface localization of fibroblast growth factor receptor 1 and cell motility. J Biol Chem (2006) 1.13
Cargo selection in vesicular transport: the making and breaking of a coat. Traffic (2002) 1.13
Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer. Clin Lung Cancer (2006) 1.12
Up-regulation of Na(+),K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer. FEBS Lett (2004) 1.09
Regulatory mechanisms of dynamin-dependent endocytosis. J Biochem (2005) 1.08
Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na,K-ATPase in A549 cells. J Cell Sci (2007) 1.03
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. Br J Cancer (2003) 1.03
Hypoxia-mediated Na-K-ATPase degradation requires von Hippel Lindau protein. FASEB J (2007) 1.00
Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma. Am J Physiol Renal Physiol (2003) 0.95
Molecular switches in metastasis. Nature (2000) 0.95
Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis. Exp Cell Res (2007) 0.95
The updated biology of hypoxia-inducible factor. EMBO J (2012) 2.49
Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem (2008) 2.38
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol (2006) 2.03
Regulation of endocytosis via the oxygen-sensing pathway. Nat Med (2009) 2.00
Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci U S A (2012) 1.80
Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J Biol Chem (2003) 1.60
pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development. Mol Cell Biol (2004) 1.45
Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis. Cancer Res (2006) 1.41
NEDD8 pathways in cancer, Sine Quibus Non. Cancer Cell (2011) 1.34
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia. Nat Med (2011) 1.31
Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J (2005) 1.30
The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway. Cancer Res (2003) 1.30
Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Am J Nephrol (2003) 1.23
Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase. J Biol Chem (2007) 1.22
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response. PLoS Genet (2008) 1.20
Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Res (2009) 1.18
Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function. J Biol Chem (2006) 1.17
Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity. Mol Cell Biol (2002) 1.16
Functional importance of Dicer protein in the adaptive cellular response to hypoxia. J Biol Chem (2012) 1.15
von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms. Cancer Res (2006) 1.14
SATB2 augments ΔNp63α in head and neck squamous cell carcinoma. EMBO Rep (2010) 1.11
Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex. Neoplasia (2006) 1.08
Dominant-negative HIF-3 alpha 4 suppresses VHL-null renal cell carcinoma progression. Cell Cycle (2007) 1.05
Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau. Curr Opin Oncol (2008) 1.03
Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain. J Biol Chem (2005) 0.95
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma. Am J Physiol Renal Physiol (2004) 0.95
Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells. Cancer Lett (2010) 0.95
NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL. EMBO Rep (2008) 0.94
Playing Tag with HIF: The VHL Story. J Biomed Biotechnol (2002) 0.93
Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response. J Virol (2006) 0.93
The role of VHL in the regulation of E-cadherin: a new connection in an old pathway. Cell Cycle (2007) 0.92
Expression of p53 in renal carcinoma cells is independent of pVHL. Mutat Res (2005) 0.92
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus. EMBO Mol Med (2010) 0.90
Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma. Lab Invest (2007) 0.89
Oxygen-independent degradation of HIF-alpha via bioengineered VHL tumour suppressor complex. EMBO Mol Med (2009) 0.87
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma. Am J Pathol (2011) 0.84
Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia. Cancer Res (2013) 0.82
DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase. Mol Cell Biol (2013) 0.82
SOCS-1 mediates ubiquitylation and degradation of GM-CSF receptor. PLoS One (2013) 0.79
Transcriptional regulation of genes via hypoxia-inducible factor. Methods Mol Biol (2012) 0.75
Molecular cloning and characterization of the von Hippel-Lindau-like protein. Mol Cancer Res (2004) 0.75